Gaurav Shah, CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 2,409 shares at $3.01 ($7K) on 2026-05-19, disclosed to the SEC on 2026-05-21.
Seasonal sale ($7k) by CEO — this insider has traded RCKT in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RCKT | SELL | 2026-05-26 | $172K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $10K | — | Filing → |
| RCKT | SELL | 2026-02-20 | $20K | — | Filing → |